(Q71347104)
Statements
Phase I and pharmacology study of intoplicine (RP 60475; NSC 645008), novel topoisomerase I and II inhibitor, in cancer patients (English)
D Abigerges
J P Armand
G G Chabot
R Bruno
M C Bissery
M Bayssas
M Klink-Alakl
M Clavel
1 February 1996